Journal

Tortus and X-on illustrate why NHS workflow integration may be a credible competitive response to expansion, provided its benefits survive practical deployment.

Updated September 2026 analysis of how Heidi, TORTUS and other rivals can respond to Tandem through workflow depth, partnerships and demonstrable customer value.

Class IIa certification is meaningful regulatory assurance. It is not proof that Heidi, Tandem or TORTUS produces the best note, and comparing certificates properly requires more t...

Tandem and TORTUS both hold Class IIa certification. As Heidi pursues the same status, the question is whether Class IIa is becoming the expected baseline for enterprise AI scribes...

Heidi, Tandem and TORTUS have taken three different routes to scale ambient AI across the NHS, and comparing them requires looking past who has the most users.

On 8 July 2026, Ortivus announced a partnership integrating TORTUS's ambient AI documentation into MobiMed, the pre-hospital record platform used by over 12,000 paramedics. Why amb...

With TORTUS reaching UKCA Class IIa and Tandem reaching EU MDR Class IIa, is device-grade certification becoming the expected bar for AI scribes rather than a differentiator? The f...

TORTUS and Tandem both claim a first Class IIa certification, and both are right. They were certified under different regimes: TORTUS under the UK's UKCA regime, Tandem under EU MD...

On 24 June 2026, TORTUS became the first ambient voice technology certified UKCA Class IIa, assessed by Scarlet (UK Approved Body 8536). What the jump from self-declared Class I to...

Tandem and Tortus are both deployed across the NHS at scale through major distribution partners, and both are climbing the medical-device regulatory ladder. They differ on regulato...

Clinical AI is not one category. Accurx, Heidi, Tortus, Tandem, OpenEvidence and iatroX occupy different layers of the workflow — communication, documentation, coding, decision sup...

AI scribes are commoditising, and the contested ground in clinical AI is shifting from documentation to the clinical decision itself — a harder, higher-stakes, more heavily regulat...